{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:52:51Z","timestamp":1793213571212,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:00:00Z","timestamp":1740268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015286","name":"Hebei Provincial Key Research Projects","doi-asserted-by":"publisher","award":["20377721D"],"award-info":[{"award-number":["20377721D"]}],"id":[{"id":"10.13039\/501100015286","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017964","name":"Tianjin Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010590","name":"Tianjin Municipal Bureau of Public Health","doi-asserted-by":"publisher","award":["TJSQNYXXR-D2-147"],"award-info":[{"award-number":["TJSQNYXXR-D2-147"]}],"id":[{"id":"10.13039\/501100010590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801231"],"award-info":[{"award-number":["81801231"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.brainresbull.2025.111273","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T10:11:09Z","timestamp":1740305469000},"page":"111273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["IL-2\/anti-IL-2 complexes attenuates neuroinflammation and neurodegeneration in mice of experimental Parkinson's disease"],"prefix":"10.1016","volume":"223","author":[{"given":"Lanxin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2025.111273_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105376","article-title":"The role of tumour necrosis factor in neuroinflammation associated with Parkinson's disease and targeted therapies","volume":"158","author":"Amin","year":"2022","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainresbull.2025.111273_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","article-title":"Alterations of T-lymphocyte populations in Parkinson disease","volume":"11","author":"Baba","year":"2005","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.brainresbull.2025.111273_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12974-022-02685-7","article-title":"Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-alpha-synuclein Parkinson's disease mice","volume":"19","author":"Badr","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.brainresbull.2025.111273_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12974-024-03024-8","article-title":"Modeling the neuroimmune system in Alzheimer's and Parkinson's diseases","volume":"21","author":"Balestri","year":"2024","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.brainresbull.2025.111273_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson's disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.brainresbull.2025.111273_bib6","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2147\/CIA.S259762","article-title":"Human adipose tissue-derived mesenchymal stem cells in Parkinson's disease: inhibition of T helper 17 cell differentiation and regulation of immune balance towards a regulatory T cell phenotype","volume":"15","author":"Bi","year":"2020","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.brainresbull.2025.111273_bib7","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/jcmm.12304","article-title":"Regulatory T cells modulate inflammation and reduce infarct volume in experimental brain ischaemia","volume":"18","author":"Brea","year":"2014","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.brainresbull.2025.111273_bib8","doi-asserted-by":"crossref","unstructured":"Chocarro, J., Lanciego, J.L., 2025. Adeno-associated viral vectors for modeling Parkinson's disease in non-human primates. Neural Regen Res.","DOI":"10.4103\/NRR.NRR-D-24-00896"},{"key":"10.1016\/j.brainresbull.2025.111273_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia function in the central nervous system during health and neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.brainresbull.2025.111273_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cyto.2015.02.025","article-title":"Toll-like receptors: activation, signalling and transcriptional modulation","volume":"74","author":"De Nardo","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.brainresbull.2025.111273_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154512","article-title":"Feruloylated oligosaccharides ameliorate MPTP-induced neurotoxicity in mice by activating ERK\/CREB\/BDNF\/TrkB signalling pathway","volume":"108","author":"Ding","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.brainresbull.2025.111273_bib12","article-title":"Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression","volume":"14","author":"Fornari Laurindo","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.brainresbull.2025.111273_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cyto.2004.06.010","article-title":"Overview of interleukin-2 function, production and clinical applications","volume":"28","author":"Gaffen","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/j.brainresbull.2025.111273_bib14","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1093\/brain\/awaa269","article-title":"CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease","volume":"143","author":"Galiano-Landeira","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.brainresbull.2025.111273_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fneur.2017.00281","article-title":"IL-2\/Anti-IL-2 complex attenuates inflammation and BBB disruption in mice subjected to traumatic brain injury","volume":"8","author":"Gao","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.brainresbull.2025.111273_bib16","article-title":"Update: descriptive epidemiology of Parkinson disease","author":"Grotewold","year":"2024","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.brainresbull.2025.111273_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122171","article-title":"TLR2 deficiency is beneficial at the late phase in MPTP-induced Parkinson' disease mice","volume":"333","author":"He","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.brainresbull.2025.111273_bib18","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1681\/ASN.2012080784","article-title":"IL-2\/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells","volume":"24","author":"Kim","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.brainresbull.2025.111273_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.brainresbull.2025.111273_bib20","article-title":"Trends and hotspots in non-motor symptoms of Parkinson's disease: a 10-year bibliometric analysis","volume":"16","author":"Li","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.brainresbull.2025.111273_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nri.2017.125","article-title":"Microglia and macrophages in brain homeostasis and disease","volume":"18","author":"Li","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.brainresbull.2025.111273_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113233","article-title":"Regulatory T cell is critical for interleukin-33-mediated neuroprotection against stroke","volume":"328","author":"Liu","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2025.111273_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12964-023-01402-y","article-title":"The involvement of alpha-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson's disease","volume":"22","author":"Miao","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.brainresbull.2025.111273_bib24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/jnr.22549","article-title":"Low-dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine causes inflammatory activation of astrocytes in nuclear factor-kappaB reporter mice prior to loss of dopaminergic neurons","volume":"89","author":"Miller","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainresbull.2025.111273_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.brainresbull.2025.111273_bib26","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191247","article-title":"Effects of interleukin-2 in immunostimulation and immunosuppression","volume":"217","author":"Pol","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.brainresbull.2025.111273_bib27","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s11064-014-1443-7","article-title":"Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons","volume":"39","author":"Prakash","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainresbull.2025.111273_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jchemneu.2015.12.002","article-title":"Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model","volume":"71","author":"Rai","year":"2016","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.brainresbull.2025.111273_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2020.101752","article-title":"Advancement in the modelling and therapeutics of Parkinson's disease","volume":"104","author":"Rai","year":"2020","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.brainresbull.2025.111273_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105798","article-title":"Age-dependent neurodegeneration and neuroinflammation in a genetic A30P\/A53T double-mutated alpha-synuclein mouse model of Parkinson's disease","volume":"171","author":"Rauschenberger","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2025.111273_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbi.2020.08.001","article-title":"Protective effect of Indole-3-carbinol, an NF-kappaB inhibitor in experimental paradigm of Parkinson's disease: In silico and in vivo studies","volume":"90","author":"Saini","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainresbull.2025.111273_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010360","article-title":"Alpha-Synuclein contribution to neuronal and glial damage in Parkinson's disease","volume":"25","author":"Saramowicz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainresbull.2025.111273_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13024-018-0255-7","article-title":"Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease","volume":"13","author":"Schutt","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.brainresbull.2025.111273_bib34","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s11481-023-10094-7","article-title":"Peripheral MC1R activation modulates immune responses and is neuroprotective in a mouse model of Parkinson's disease","volume":"18","author":"Srivastava","year":"2023","journal-title":"J. Neuroimmun. Pharmacol."},{"key":"10.1016\/j.brainresbull.2025.111273_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1165","article-title":"Efficacy, safety and the lymphocyte subsets changes of low-dose IL-2 in patients with systemic lupus erythematosus: a systematic review and meta-analysis","volume":"12","author":"Su","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.brainresbull.2025.111273_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40744-023-00620-7","article-title":"Efficacy, safety and the lymphocyte subset changes of low-dose IL-2 in patients with autoimmune rheumatic diseases: a systematic review and meta-Analysis","volume":"11","author":"Su","year":"2024","journal-title":"Rheuma Ther."},{"key":"10.1016\/j.brainresbull.2025.111273_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41531-024-00640-2","article-title":"Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson's disease mouse model","volume":"10","author":"Thi Lai","year":"2024","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.brainresbull.2025.111273_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41531-021-00188-5","article-title":"Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson's disease","volume":"7","author":"Thome","year":"2021","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.brainresbull.2025.111273_bib39","first-page":"45","article-title":"From TGN1412 to TAB08: the return of CD28 superagonist therapy to clinical development for the treatment of rheumatoid arthritis","volume":"34","author":"Tyrsin","year":"2016","journal-title":"Clin. Exp. Rheuma"},{"key":"10.1016\/j.brainresbull.2025.111273_bib40","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2153534","article-title":"Regulatory T cell therapy for multiple sclerosis: breaching (blood-brain) barriers","volume":"18","author":"Verreycken","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.brainresbull.2025.111273_bib41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41421-021-00280-3","article-title":"Single-cell transcriptome and TCR profiling reveal activated and expanded T cell populations in Parkinson's disease","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Discov."},{"key":"10.1016\/j.brainresbull.2025.111273_bib42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12967-024-04881-w","article-title":"MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson's disease","volume":"22","author":"Wang","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.brainresbull.2025.111273_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson's disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.brainresbull.2025.111273_bib44","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1159\/000485818","article-title":"The IL-2\/Anti-IL-2 complex attenuates cardiac ischaemia-reperfusion injury through expansion of regulatory T cells","volume":"44","author":"Xiao","year":"2017","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.brainresbull.2025.111273_bib45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13024-023-00692-7","article-title":"Amyloid-beta specific regulatory T cells attenuate Alzheimer's disease pathobiology in APP\/PS1 mice","volume":"18","author":"Yeapuri","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.brainresbull.2025.111273_bib46","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.4049\/jimmunol.1701502","article-title":"IL-2-Anti-IL-2 monoclonal antibody immune complexes inhibit collagen-induced arthritis by augmenting regulatory T cell functions","volume":"201","author":"Yokoyama","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.brainresbull.2025.111273_bib47","first-page":"1","article-title":"Low-dose IL-2 therapy in autoimmune diseases: an update review","author":"Zhang","year":"2023","journal-title":"Int. Rev. Immunol."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923025000851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923025000851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:51:47Z","timestamp":1778543507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923025000851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":47,"alternative-id":["S0361923025000851"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2025.111273","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-2\/anti-IL-2 complexes attenuates neuroinflammation and neurodegeneration in mice of experimental Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2025.111273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111273"}}